entertainment -WSS

entertainment

author：Wikipedia 2025-09-03 11:20:45 - browse：96522

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Brain 'hot spot' may explain why African Americans feel greater pain

entertainment

hotspot

entertainment

WSS

4th of July breaks record for highest global temperature ever measured

Biden praises World Series champion Astros for impact off the field during White House celebration

An Ebola outbreak presents a new mystery involving children

Hospitals use virtual reality to design more inclusive rooms for kids

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Lessons Learned: This is why you network to find that industry job you want

leisure time

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

How to save PrEP access — and even expand it

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Supreme Court strikes down use of affirmative action

Connecting traumatic brain injury and domestic violence

Continuity nursing helped my family in our darkest PICU moments

Brain 'hot spot' may explain why African Americans feel greater pain

Walensky prepares to leave CDC — and Congress — behind

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

How to save PrEP access — and even expand it

7 people shot in DC, police say

explore

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

More regulation could be coming for drug ads

An Ebola outbreak presents a new mystery involving children

Can food be medicine? And other questions about a new push

entertainment

hotspot

entertainment

focus